Drugs / Centella asiatica

Trials 4 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT05591027 Dec 2022 → Nov 2025 overdue Alzheimer disease, cognitive impairment with or without cerebellar ataxia Oregon Health and Science University Recruiting No outcome recorded
Phase 1 NCT02827305 Aug 2015 gingival disorder Sri Hasanamba Dental College and Hospital Completed No outcome recorded
Phase 31 trial
Phase 3 NCT01414374 Jan → Dec 2012 iron deficiency anemia Casa Espirita Terra de Ismael Completed No outcome recorded
Phase not applicable1 trial
NCT07697209 Mar → Sep 2025 periodontitis Mansoura University Completed No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT04886882 Comparator Mar → Jun 2021 Başakşehir Çam & Sakura City Hospital Unknown No outcome recorded
Phase 41 trial
Phase 4 NCT03815305 Comparator Jul 2018 → Jan 2019 type 2 diabetes mellitus Indonesia University Unknown No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as Centella asiatica Centella asiatica tincture, 40 drops, BID” NCT01414374
4

“1% centella asiatica ointment” NCT03815305

NCT07697209

NCT04886882

NCT05591027

Known as C. asiatica “Group I (study group): 15 Patients with periodontitis Stage III will be treated with C. asiatica nanoemulsion as an adjunct to SRP.” NCT07697209
Known as Gotukola ClinicalTrials.gov intervention name — accepted as the source's own label NCT02827305
Modality Traditional medicine (herbal / TCM) “a composite herbal medicine (Hibiscus sabdariffa plus Centella asiatica)” NCT01414374
Route Topical “1% centella asiatica ointment” NCT03815305